REVIVA PHARMACEUTICALS INC has a total of 103 patent applications. It increased the IP activity by 20.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PRODESFARMA SA, DOMPE PHA R MA SPA and PRESCIENT NEUROPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 19 | |
#2 | WIPO (World Intellectual Property Organization) | 11 | |
#3 | China | 10 | |
#4 | EPO (European Patent Office) | 10 | |
#5 | Brazil | 6 | |
#6 | Australia | 5 | |
#7 | Canada | 5 | |
#8 | Israel | 5 | |
#9 | Mexico | 5 | |
#10 | South Africa | 5 | |
#11 | Hong Kong | 3 | |
#12 | New Zealand | 3 | |
#13 | Colombia | 2 | |
#14 | Japan | 2 | |
#15 | Republic of Korea | 2 | |
#16 | Philippines | 2 | |
#17 | Singapore | 2 | |
#18 | Ukraine | 2 | |
#19 | Hungary | 1 | |
#20 | India | 1 | |
#21 | Malaysia | 1 | |
#22 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bhat Laxminarayan | 86 |
#2 | Bhat Seema Rani | 50 |
#3 | Adiey Kouacou | 39 |
#4 | Mohapatra Prabhu Prasad | 31 |
#5 | Cantillon Marc | 14 |
#6 | Laxminarayan Bhat | 10 |
#7 | Kouacou Adiey | 7 |
#8 | Mohapatra Prabhu P | 7 |
#9 | Wallis Ellen M | 5 |
#10 | Seema Rani Bhat | 4 |
Publication | Filing date | Title |
---|---|---|
US2019142838A1 | Methods for treating parkinson's disease | |
CN111770755A | Methods of treating pulmonary fibrosis | |
WO2016115150A1 | Methods for treating psychosis associated with parkinson's disease | |
WO2016115144A1 | Methods for treating alzheimer's disease | |
EP3244896A1 | Methods for treating pulmonary hypertension | |
WO2015157451A1 | Methods for treating attention deficit hyperactivity disorder | |
US2014024679A1 | Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives | |
WO2012003501A2 | Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives | |
WO2010099502A1 | Compositions, synthesis, and methods of utilizing arylpiperazine derivatives | |
CN101626688A | Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors | |
BRPI0716952A2 | COMPOUND, METHODS FOR TREATING AND / OR PREVENTING OBESITY OR CO-MORBID INDICATION RELATED TO OBESITY, AND FOR SYNTHESIZING CYCLOalkylmethylamine Derivatives |